Allergy/Asthma News

Extended use of omalizumab up to 1 year showed efficacy for the treatment of uncontrolled chronic rhinosinusitis with nasal polyps, according to long-term results published in The Journal of Allergy and Clinical Immunology.

Tezepelumab reduces exacerbations among patients who have severe asthma, including some types of asthma that lack other effective biologic therapies, according to a draft evidence report by the Institute for Clinical and Economic Review.

BreatheSuite announced that it received 510(k) clearance from the FDA for its Metered-Dose Inhaler V1 device, which turns existing inhalers into smart inhalers for people with asthma and COPD, according to a company press release.

Although there is a link between allergic disease and mental health, this relationship does not appear to be causal, according to a study published in Clinical & Experimental Allergy.

Infants with high consumption of infant formula and other strongly heat-treated milk products demonstrated increased risk for asthma, according to a study published by Pediatric Allergy and Immunology.

A digital mindfulness intervention was feasible and associated with benefits in quality of life among adults with asthma, according to data published in the Journal of Behavioral Medicine.

Media coverage of fatalities that result from food allergies contributes to the anxieties and fear felt by children with food allergies and their parents, according to a letter to the editor published in Pediatric Allergy and Immunology.

Black children with food allergies had less access to allergen-free foods compared with white children, based primarily on socioeconomic status and education, according to a study.

National Penicillin Allergy Day is Sept. 28, which acknowledges the day in 1928 when Sir Alexander Fleming, FRS, FRSE, FRCS, discovered that Penicillium mold secretes an antibacterial substance.

In a new study, approved asthma biologics and systemic corticosteroids were not associated with an increased risk for SARS-CoV-2 infection, but use of systemic corticosteroids was linked with worse COVID-19 outcomes.